Anke Verlinden

651 total citations
20 papers, 212 citations indexed

About

Anke Verlinden is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Anke Verlinden has authored 20 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Hematology and 6 papers in Immunology. Recurrent topics in Anke Verlinden's work include Neutropenia and Cancer Infections (5 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Mast cells and histamine (4 papers). Anke Verlinden is often cited by papers focused on Neutropenia and Cancer Infections (5 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Mast cells and histamine (4 papers). Anke Verlinden collaborates with scholars based in Belgium, Netherlands and Austria. Anke Verlinden's co-authors include Zwi Berneman, Wilfried Schroyens, Alain Gadisseur, Herman Goossens, Hilde Jansens, Diana Averbuch, Małgorzata Mikulska, Nina Knelange, Jan Styczyński and Ann Van de Velde and has published in prestigious journals such as Blood, British Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Anke Verlinden

19 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anke Verlinden Belgium 9 108 62 54 43 34 20 212
Paula Yurie Tanaka Brazil 9 168 1.6× 48 0.8× 62 1.1× 16 0.4× 64 1.9× 20 286
A. Ali Zirakzadeh Sweden 8 161 1.5× 26 0.4× 49 0.9× 119 2.8× 39 1.1× 13 300
Yıldız Yildirmak Türkiye 12 44 0.4× 25 0.4× 114 2.1× 40 0.9× 59 1.7× 31 326
Savaş Kansoy Türkiye 10 29 0.3× 14 0.2× 55 1.0× 43 1.0× 48 1.4× 18 219
Martin Castelle France 10 31 0.3× 17 0.3× 119 2.2× 94 2.2× 36 1.1× 21 282
Álvaro Urbano Spain 8 87 0.8× 12 0.2× 138 2.6× 74 1.7× 34 1.0× 9 242
Mahfuzah Mohamed Malaysia 8 187 1.7× 35 0.6× 13 0.2× 18 0.4× 31 0.9× 10 332
Elif İnce Türkiye 9 42 0.4× 11 0.2× 122 2.3× 22 0.5× 32 0.9× 37 243
Jean Maupas France 8 81 0.8× 22 0.4× 168 3.1× 32 0.7× 35 1.0× 14 281
Luisa Verga Italy 10 143 1.3× 19 0.3× 77 1.4× 24 0.6× 122 3.6× 33 288

Countries citing papers authored by Anke Verlinden

Since Specialization
Citations

This map shows the geographic impact of Anke Verlinden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Verlinden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Verlinden more than expected).

Fields of papers citing papers by Anke Verlinden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Verlinden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Verlinden. The network helps show where Anke Verlinden may publish in the future.

Co-authorship network of co-authors of Anke Verlinden

This figure shows the co-authorship network connecting the top 25 collaborators of Anke Verlinden. A scholar is included among the top collaborators of Anke Verlinden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Verlinden. Anke Verlinden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elst, Jessy, Marie‐Line M. van der Poorten, Athina L. Van Gasse, et al.. (2022). Mastocytosis and related entities: a practical roadmap. Acta Clinica Belgica. 78(4). 325–335. 3 indexed citations
2.
Elst, Jessy, Didier G. Ebo, Margaretha A. Faber, et al.. (2022). Overexpression of FcεRI on Bone Marrow Mast Cells, but Not MRGPRX2, in Clonal Mast Cell Disorders With Wasp Venom Anaphylaxis. Frontiers in Immunology. 13. 835618–835618. 8 indexed citations
3.
Ebo, Didier G., Jessy Elst, Margaretha A. Faber, et al.. (2021). Diagnosis of Primary Mast Cell Disorders in Anaphylaxis: Value of KIT D816V in Peripheral Blood. The Journal of Allergy and Clinical Immunology In Practice. 9(8). 3176–3187.e3. 10 indexed citations
4.
Elst, Jessy, Didier G. Ebo, Margaretha A. Faber, et al.. (2021). Culturing cells with mast cell phenotype and function: Comparison of peripheral blood and bone marrow as a source.. Journal of Immunological Methods. 495. 113061–113061. 8 indexed citations
5.
Rasschaert, Marika, Ella Roelant, Hans Prenen, et al.. (2021). The tele-transition of toxicity management in routine oncology care during the severe acute respiratory syndrome (SARS-CoV-2) pandemic. British Journal of Cancer. 124(8). 1366–1372. 3 indexed citations
6.
Brusselen, Daan Van, et al.. (2021). A case of multisystem inflammatory syndrome (MIS-A) in an adult woman 18 days after COVID-19 vaccination. Acta Clinica Belgica. 77(4). 772–777. 8 indexed citations
7.
Verlinden, Anke, Hilde Jansens, Herman Goossens, et al.. (2021). Safety and Efficacy of Antibiotic De-escalation and Discontinuation in High-Risk Hematological Patients With Febrile Neutropenia: A Single-Center Experience. Open Forum Infectious Diseases. 9(3). ofab624–ofab624. 29 indexed citations
8.
Verlinden, Anke, et al.. (2020). Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey. Bone Marrow Transplantation. 55(8). 1588–1594. 40 indexed citations
9.
Verlinden, Anke, Karolien Beel, Dries Deeren, et al.. (2020). Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature. Acta Clinica Belgica. 76(6). 500–508. 15 indexed citations
10.
Verlinden, Anke, et al.. (2020). A case series of 3 patients with acute colonic pseudo-obstruction after vincristine administration.. Acta gastro-enterologica belgica. 83(4). 660–662.
11.
Verlinden, Anke, Véronique De Vroey, Herman Goossens, et al.. (2019). COMPARISON OF THE POWER OF PROCALCITONIN AND C-REACTIVE PROTEIN TO DISCRIMINATE BETWEEN DIFFERENT AETIOLOGIES OF FEVER IN PROLONGED PROFOUND NEUTROPENIA: A SINGLE-CENTRE PROSPECTIVE OBSERVATIONAL STUDY.. Mediterranean Journal of Hematology and Infectious Diseases. 11(1). e2019023–e2019023. 9 indexed citations
12.
13.
14.
Berneman, Zwi, et al.. (2017). Adult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesions. Experimental Hematology and Oncology. 6(1). 9–9. 7 indexed citations
15.
Couttenye, Marie M., B. Bracke, Dirk Ysebaert, et al.. (2017). Passenger Lymphocyte Syndrome (PLS): A Single-center Retrospective Analysis of Minor ABO-incompatible Liver Transplants. Journal of Clinical and Translational Hepatology. 5(1). 9–15. 9 indexed citations
16.
Beutels, Philippe, Evelien Smits, Viggo Van Tendeloo, et al.. (2016). Medical costs of treatment and survival of patients with acute myeloid leukemia in Belgium. Leukemia Research. 46. 26–29. 8 indexed citations
17.
Janssens, Katrien, Kathleen Deiteren, Anke Verlinden, et al.. (2016). Detection of a case of chronic myeloid leukaemia with deletions at the t(9;22) translocation breakpoints by a genome-wide non-invasive prenatal test. Prenatal Diagnosis. 36(8). 760–765. 6 indexed citations
18.
Verlinden, Anke, Hilde Jansens, Herman Goossens, et al.. (2014). Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia. European Journal Of Haematology. 93(4). 302–308. 23 indexed citations
19.
Anguille, Sébastien, Philippe Beutels, Griet Nijs, et al.. (2014). Cost Analysis of Immunotherapy Using Dendritic Cells for Acute Myeloid Leukemia Patients. Blood. 124(21). 1322–1322. 3 indexed citations
20.
Verlinden, Anke, et al.. (2013). Determining factors predictive of CD34+ cell collection efficiency in an effort to avoid extended and repeated apheresis sessions. Journal of Clinical Apheresis. 28(6). 404–410. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula Yurie Tanaka Breakdown of academic impact, for papers by A. Ali Zirakzadeh Breakdown of academic impact, for papers by Yıldız Yildirmak Breakdown of academic impact, for papers by Savaş Kansoy Breakdown of academic impact, for papers by Martin Castelle Breakdown of academic impact, for papers by Álvaro Urbano Breakdown of academic impact, for papers by Mahfuzah Mohamed Breakdown of academic impact, for papers by Elif İnce Breakdown of academic impact, for papers by Jean Maupas Breakdown of academic impact, for papers by Luisa Verga
Rankless by CCL
2026